FDA Approves Game-Changing Immunotherapy Drug to Fight Lung Cancer
In an unprecedented study conducted at UCLA and 29 other sites worldwide, Keytruda (pembrolizumab) was found to be effective in the treatment of patients with advanced non-small cell lung cancer U.S. Food and Drug Administration has approved the groundbreaking immunotherapy drug Keytruda (pembrolizumab) to treat advanced non-small cell lung cancer (NSCLC) Three-year international study led […]